CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, and Kelun-Biotech...
Hence then, the article about harbour biomed and kelun biotech announce nmpa approval of ind application for hbm7575 skb575 for the treatment of asthma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma )
Also on site :
- Tractor Supply's 'Beautiful' $100 Kitchen Essential Looks Just Like a Le Creuset Style Over 4x the Price
- Brote de diarrea por parásitos se expande a más estados de EE.UU. mientras los casos superan el nivel del año pasado
- 1968 Banned Rock Classic, Ranked Among 'Greatest Songs of All Time,' Was Recorded With a Toy Drum Set